Yutaka Yonemitsu

1.2k total citations
30 papers, 890 citations indexed

About

Yutaka Yonemitsu is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Yutaka Yonemitsu has authored 30 papers receiving a total of 890 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hepatology, 24 papers in Epidemiology and 3 papers in Molecular Biology. Recurrent topics in Yutaka Yonemitsu's work include Liver Disease Diagnosis and Treatment (21 papers), Hepatitis B Virus Studies (14 papers) and Hepatitis C virus research (14 papers). Yutaka Yonemitsu is often cited by papers focused on Liver Disease Diagnosis and Treatment (21 papers), Hepatitis B Virus Studies (14 papers) and Hepatitis C virus research (14 papers). Yutaka Yonemitsu collaborates with scholars based in Japan and United States. Yutaka Yonemitsu's co-authors include Osamu Yokosuka, Keiichi Fujiwara, Fumio Imazeki, Shin Yasui, Makoto Arai, Tatsuo Kanda, Shigeto Oda, Kenichi Fukai, Masayuki Nakano and Tetsuhiro Chiba and has published in prestigious journals such as Cancer Research, Journal of Hepatology and Human Pathology.

In The Last Decade

Yutaka Yonemitsu

30 papers receiving 876 citations

Peers

Yutaka Yonemitsu
Anke Liepelt Germany
Yutaka Yonemitsu
Citations per year, relative to Yutaka Yonemitsu Yutaka Yonemitsu (= 1×) peers Anke Liepelt

Countries citing papers authored by Yutaka Yonemitsu

Since Specialization
Citations

This map shows the geographic impact of Yutaka Yonemitsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yutaka Yonemitsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yutaka Yonemitsu more than expected).

Fields of papers citing papers by Yutaka Yonemitsu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yutaka Yonemitsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yutaka Yonemitsu. The network helps show where Yutaka Yonemitsu may publish in the future.

Co-authorship network of co-authors of Yutaka Yonemitsu

This figure shows the co-authorship network connecting the top 25 collaborators of Yutaka Yonemitsu. A scholar is included among the top collaborators of Yutaka Yonemitsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yutaka Yonemitsu. Yutaka Yonemitsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fujiwara, Keiichi, et al.. (2011). Advanced histology and impaired liver regeneration are associated with disease severity in acute-onset autoimmune hepatitis. Histopathology. 58(5). 693–704. 26 indexed citations
2.
Kanda, Tatsuo, Fumio Imazeki, Shigeru Mikami, et al.. (2011). Occurrence of Hepatocellular Carcinoma Was Not a Rare Event during and Immediately after Antiviral Treatment in Japanese HCV-Positive Patients. Oncology. 80(5-6). 366–372. 12 indexed citations
3.
Fujiwara, Keiichi, Shin Yasui, Akinobu Tawada, et al.. (2011). Autoimmune fulminant liver failure in adults: Experience in a Japanese center. Hepatology Research. 41(2). 133–141. 31 indexed citations
4.
Yasui, Shin, et al.. (2011). Importance of computed tomography imaging features for the diagnosis of autoimmune acute liver failure. Hepatology Research. 42(1). 42–50. 35 indexed citations
5.
Imazeki, Fumio, Tomoko Kurihara, Kenichi Fukai, et al.. (2011). Pegylated interferon-alfa-2a monotherapy in patients infected with HCV genotype 2 and importance of rapid virological response. BMC Research Notes. 4(1). 316–316. 5 indexed citations
6.
Kanda, Tatsuo, Fumio Imazeki, Ryosaku Azemoto, et al.. (2011). Response to Peginterferon-alfa 2b and Ribavirin in Japanese Patients with Chronic Hepatitis C Genotype 2. Digestive Diseases and Sciences. 56(11). 3335–3342. 20 indexed citations
7.
Arai, Makoto, Fumio Imazeki, Yutaka Yonemitsu, et al.. (2010). Long‐term follow‐up of patients with hepatitis B e antigen negative chronic hepatitis B. Journal of Gastroenterology and Hepatology. 26(1). 122–128. 10 indexed citations
8.
Okitsu, Kohichiroh, Tatsuo Kanda, Fumio Imazeki, et al.. (2010). Involvement of Interleukin-6 and Androgen Receptor Signaling in Pancreatic Cancer. Genes & Cancer. 1(8). 859–867. 49 indexed citations
9.
Wu, Shuang, Fumio Imazeki, Fuat Kurbanov, et al.. (2010). Evolution of hepatitis B genotype C viral quasi-species during hepatitis B e antigen seroconversion. Journal of Hepatology. 54(1). 19–25. 13 indexed citations
10.
Fujiwara, Keiichi, et al.. (2010). The requirement for a sufficient period of corticosteroid treatment in combination with nucleoside analogue for severe acute exacerbation of chronic hepatitis B. Journal of Gastroenterology. 45(12). 1255–1262. 24 indexed citations
11.
Fujiwara, Keiichi, Hiroshige Kojima, Shin Yasui, et al.. (2010). Hepatitis A viral load in relation to severity of the infection. Journal of Medical Virology. 83(2). 201–207. 19 indexed citations
12.
Wu, Shuang, Kenichi Fukai, Fumio Imazeki, et al.. (2010). Initial Virological Response and Viral Mutation with Adefovir Dipivoxil Added to Ongoing Lamivudine Therapy in Lamivudine-Resistant Chronic Hepatitis B. Digestive Diseases and Sciences. 56(4). 1207–1214. 9 indexed citations
13.
Fujiwara, Keiichi, Hiroshige Kojima, Yutaka Yonemitsu, et al.. (2009). Phylogenetic analysis of hepatitis A virus in sera from patients with hepatitis A of various severities. Liver International. 29(6). 838–845. 14 indexed citations
14.
Yonemitsu, Yutaka, Fumio Imazeki, Tetsuhiro Chiba, et al.. (2009). Distinct expression of polycomb group proteins EZH2 and BMI1 in hepatocellular carcinoma. Human Pathology. 40(9). 1304–1311. 54 indexed citations
15.
Matsumura, Tomoaki, Makoto Arai, Yutaka Yonemitsu, et al.. (2009). The traditional Japanese medicine Rikkunshito increases the plasma level of ghrelin in humans and mice. Journal of Gastroenterology. 45(3). 300–307. 76 indexed citations
16.
Nakamoto, Shingo, Fumio Imazeki, Kenichi Fukai, et al.. (2009). Association between mutations in the core region of hepatitis C virus genotype 1 and hepatocellular carcinoma development. Journal of Hepatology. 52(1). 72–78. 49 indexed citations
17.
Nakamoto, Shingo, Tatsuo Kanda, Yutaka Yonemitsu, et al.. (2009). Quantification of hepatitis C amino acid substitutions 70 and 91 in the core coding region by real-time amplification refractory mutation system reverse transcription-polymerase chain reaction. Scandinavian Journal of Gastroenterology. 44(7). 872–877. 14 indexed citations
18.
Arai, Makoto, Fumio Imazeki, Yutaka Yonemitsu, et al.. (2009). Opportunistic infection in the patients with acute liver failure: a report of three cases with one fatality. Clinical Journal of Gastroenterology. 2(6). 420–424. 4 indexed citations
19.
Chiba, Tetsuhiro, Satoru Miyagi, Atsunori Saraya, et al.. (2008). The Polycomb Gene Product BMI1 Contributes to the Maintenance of Tumor-Initiating Side Population Cells in Hepatocellular Carcinoma. Cancer Research. 68(19). 7742–7749. 160 indexed citations
20.
Fujiwara, Keiichi, Shin Yasui, Yutaka Yonemitsu, et al.. (2008). Efficacy of combination therapy of antiviral and immunosuppressive drugs for the treatment of severe acute exacerbation of chronic hepatitis B. Journal of Gastroenterology. 43(9). 711–719. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026